_______________________________________________

-  THE FRIDAY LETTER  -

(emailed weekly, from Gilder Publishing,
for friends and subscribers)

__________________________________________________


 | http://www.gilder.com/ | Issue 271.0/November 10, 2006

SIGN-UP A FRIEND FOR FREE!
 

 

HEADLINES:

-  The Week / Human Health in the Telecosm
-  Friday Feature / What’s your exit strategy?
-  Friday Blogger Bonus / Global Warming Is a Myth
-  Readings /

 

The Week / Human Health in the Telecosm

Dr. Arthur Robinson, Founder, Oregon Institute of Science and Medicine, speaking at Gilder/Forbes Telecosm 2006 last month in Lake Tahoe (transcribed excerpt):

Something needs to be done in medicine and the entrepreneurs and technologists of the telecosm are the exact people to do it.  It involves moving diagnostic medicine into the hands of the consumers—taking the diagnostic and technological tools of medicine and making computer peripherals out of them, as well as making on-person monitors and turning the Internet into an interpretive tool, so that the consumers of medicine can evaluate the product that they receive and medicine itself could be turned into a therapeutic industry competing on the basis of quality and price.

 

My youngest son Matthew has a dog named Rusty. When Matthew takes Rusty to the veterinarian, the vet can take a blood sample from Rusty, put it in a computer peripheral beside his PC, which costs $1,000, get the analysis in a few minutes, diagnose Rusty, and go on about his business. It measures the same couple of dozen things that would be measured if you went to a physician. Some veterinarians, in fact, send their samples to the local hospital and put them through the same medical devices used for humans.

 

In any case, the veterinarian can do this for Rusty, but he can’t do this for Matthew. If he measured Matthew’s sample, that would be unlawful. And, if a physician had this device in his office, he also couldn’t use it. That also would be unlawful. The only people allowed to use these devices are working in approved commercial clinical laboratories, and most of those laboratories would not measure a sample if Matthew asked them to do it. But, there is an out. Matthew can measure his own sample. If he does it himself, it is lawful.

 

Medicine is an odd industry. It is a monopoly that controls not only the product it produces but also the evaluation of its own product. This is a historical result. Initially medicine had very little technology. What was known about medicine resided in the minds of the physicians.


As technology developed for medicine, especially diagnostic technology, this technology involved very expensive machinery and evolved in a time when computers were very expensive. It was just not possible for the people being helped by medicine to handle their own diagnostic work. The industry grew up measuring samples commercially. (It is now about a $100 billion industry.) But, as the monopoly matured, these commercial laboratories disappeared behind the gatekeepers of medicine, so that the individual cannot use high technology or evaluate the product that he is using. Moreover, the technology advances at a slow rate…

 

The thing that holds back medicine is the quantitative measurement of health. It is necessary to be able to measure quantitatively to make an advance. And yet it is very difficult to do.

Why would you want to do this?

Suppose you could measure the percentage of life remaining to you or at least your physiological age, quantitatively. Things would change. Someone may tell you you’ll live longer if you eat more Vitamin E or exercise or eat your veggies. You can do those things and have the opportunity to go back and re-measure to see if these life style changes have changed your rate of aging either positively or negatively.

The second reason for measuring health quantitatively is the probability of illness. And the third is, if you do get sick, you need to be able to measure your sickness quantitatively.

If you develop cancer and your physician suggests three or four options. What do you do? You pick the one that looks the best and close your eyes and see if you die. It shouldn’t be that way. You should be able to pick a method, watch the rate of growth of the cancer as a function of time, see if it’s improved or made worse by what you are doing, and then modulate and adjust your method of battling the illness…


The greatest amount of information is held in the metabolites, the small molecules found in urine, blood, and saliva that are produced and consumed in the normal course of metabolism. They are where the action is and they are all interlocked in different bio-chemical pathways. You don’t have to measure any specific one. There may be 5,000 of them in there, but if you take a sample of 200, those 200 are carrying information about the other 4,800. For example, 30 percent of the substances in your urine are correlated with your physiological age.

 

You can obtain tremendous amounts of information by profiling these molecules it is not being done…

 

Find out how human suffering could be decreased and the human lifespan increased using the technologies of the telecosm. Listen to Dr. Robinson’s complete Telecosm 2006 talk by downloading the MP3 audio file available on: http://www.gildertech.com/public/Telecosm2006/Agenda.htm#health

George Gilder’s telecosm technologies portfolio is up 307% since the market low
in October 2002, compared to 109% for the NASDAQ and just 76% for the S&P 500.

With a 15% gain over the last 52 weeks, the Gilder Technology Report continues to strengthen subscriber portfolios with picks such as network processor startup EZchip up 157% for the year.


SUBSCRIBE TO THE GILDER TECHNOLOGY REPORT TODAY
 (Numbers based on performance data analyzed independently on www.gtindex.com.)  
http://www.gildertech.com/


Friday Feature / What’s your exit strategy?

Excerpted posts from the www.Gildertech.com subscriber-only message board.

Gilder Technology Report Subscriber #1 (11/4/06):
What is your exit strategy assuming EZchip (LNOP) does well? I hope to have the discipline to sell some as it goes up but I need a plan.

George Gilder (11/4/06): In general, unless I can see a clear path toward large new markets, I tend to sell half my shares after a double or triple. So should you if it becomes disproportionate in your portfolio. You should always be ready to sell half or more of your shares when a company has soared beyond easy explanation or justification.


Equally you should always be ready to make prudent purchases of shares when they fall as a result of overreaction or panic. Today this condition might apply to Altera (ALTR), PMC-Sierra (PMCS), NetLogic (NETL), Ikanos (IKAN), Qualcomm (QCOM), Anadigics (ANAD), Corning (GLW), Marvell (MRVL), Zoran (ZRAN), and even Microvision (MVIS). 


GTR Subscriber #2 (11/4/06): I also hope the members of this board still do the due diligence required to ride LNOP and explain and discuss if it has overreached, underreached, or is in the right place. George, Thanks to you and Charlie and the other major [message board] contributors for uncovering this opportunity.

Logon with your subscriber ID at www.Gildertech.com to read more posts by George Gilder and fellow GTR subscribers.

 

The Gildertech Blog, http://blog.gildertech.com/ | Logon now to see what’s new.


Friday Blogger Bonus
/ Science Has Spoken: Global Warming Is a Myth
 
The
global-warming hypothesis is no longer tenable. Scientists have been able to test it carefully, and it does not hold up. During the past 50 years, as atmospheric carbon dioxide levels have risen, scientists have made precise measurements of atmospheric temperature. These measurements have definitively shown that major atmospheric greenhouse warming of the atmosphere is not occurring and is unlikely ever to occur.

The temperature of the atmosphere fluctuates over a wide range, the result of solar activity and other influences. During the past 3,000 years, there have been five extended periods when it was distinctly warmer than today. One of the two coldest periods, known as the Little Ice Age, occurred 300 years ago. Atmospheric temperatures have been rising from that low for the past 300 years, but remain below the 3,000-year average….

Read the 1997 paper, written by
Arthur Robinson (featured in today’s  Friday Letter “The Week” section)  and Zachary Robinson of the Oregon Institute of Science and Medicine, and check out “The Global Warming Hoax” blog:
http://globalwarminghoax.wordpress.com/2006/10/25/science-has-spokenglobal-warming-is-a-myth/

Did you miss Telecosm 2006?
Or did you attend, and find yourself wishing you could experience once again the musical thrill of a lifetime? Pay a visit to Jeff Stambovsky's Telecosm Songbook!! You'll hear musical tributes to George Gilder and other Telecosm luminaries of the past ten years, the people who made the future come true.

Listen now at www.telecosmsongs.blogspot.com.

 

Readings /

Next Inning Technology Updates Outlooks for Altera, Microvision, SiRF Technology, and Texas Instruments: http://biz.yahoo.com/prnews/061108/ph00661.html?.v=1

Microsoft Unveils 3-D Maps In Latest Bid To Upstage Google

http://www.technologyreview.com/read_article.aspx?id=17771&ch=biztech

 

Gannett To Crowdsource News
http://www.wired.com/news/culture/media/0,72067-0.html?tw=wn_technology_internet_13

 

Verizon’s Big TV Bet Goes Small-Town
http://www.forbes.com/2006/11/05/verizon-cable-tv-tech-intel-cx_df_1106verizon.html?partner=telecom_newsletter

 

Nvidia’s New Graphics Chip Takes On Added Duties
http://www.siliconvalley.com/mld/siliconvalley/15962897.htm

 

Silicon And Sun
http://www.technologyreview.com/read_article.aspx?id=17726&ch=nanotech

 

Cheap, Superefficient Solar

http://www.technologyreview.com/read_article.aspx?id=17774&ch=energy

 

Bad Trade-Off
http://article.nationalreview.com/?q=MTA0ZjVkNTA3OWY4YjQyZjM0NDFkMTY1NTI0NjY3NmQ=

__________________________________________

SIGN-UP A FRIEND FOR FREE!
Click here to add a friend to our Friday Letter mailing list.
__________________________________________


FRIDAY LETTER STAFF

Editor: Mary Collins / mcollins@gilder.com

Research: Sandy Fleischmann / sfleischmann@gilder.com

 

ADVERTISING INFORMATION

The Friday Letter is mailed each week to more than 150,000-plus subscribers and friends of Gilder Publishing, including industry leaders, financial professionals and individual investors. For information about advertising, contact Mary Collins at mcollins@gilder.com.

PLEASE NOTE: The appearance of an advertisement in the Friday Letter does not indicate an endorsement for the product and/or service by George Gilder, Gilder Publishing LLC, or the Friday Letter staff.

 

FEEDBACK AND PROBLEMS

For technical problems, or to send letters to the editor, please e-mail info@gilder.com.

 

MAILING ADDRESS

Gilder Publishing, LLC

ATTN: Friday Letter

291A Main Street

Great Barrington, MA 01230

_______________________________________________

The Friday Letter is published weekly for subscribers and friends of Gilder Publishing. If someone you know would enjoy it, please feel free to forward a copy.

 

Gilder Publishing makes the Friday Letter available for free. To help defray some of the costs of producing this information on a weekly basis, we will from time to time be sending you offers from companies we think you'll be interested in. These offers will not come more than once a week. If you do not wish to receive this related information, please opt out of this process at the link below and we will not share your name with companies outside of Gilder Publishing.

 

http://www.gilder.com/unsubscribe/specialproducts.php

 

To SUBSCRIBE please visit http://www.gilder.com/

To UNSUBSCRIBE please go to http://www.gilder.com/fridayletter/unsubscribe.php

 

Trouble subscribing or unsubscribing?

Email info@gilder.com

_______________________________________________

Copyright 2006 Gilder Publishing LLC